DexCom
DXCM
962 hedge funds and large institutions have $23.4B invested in DexCom in 2026 Q1 according to their latest regulatory filings, with 152 funds opening new positions, 375 increasing their positions, 324 reducing their positions, and 97 closing their positions.
57% more first-time investments, than exits
New positions opened: 152 | Existing positions closed: 97
16% more repeat investments, than reductions
Existing positions increased: 375 | Existing positions reduced: 324
4% more funds holding
Funds holding: 922 → 962 (+40)
7% more call options, than puts
Call options by funds: $255M | Put options by funds: $238M
0.89% more ownership
Funds ownership: 95.75% → 96.64% (+0.89%)
6% less capital invested
Capital invested by funds: $24.9B → $23.4B (-$1.5B)
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$435M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$299M |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$169M |
| 4 |
Toronto Dominion Bank
Toronto, Ontario,
Ontario, Canada
|
+$156M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
+$147M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$330M |
| 2 |
D.E. Shaw & Co
New York
|
-$272M |
| 3 |
Nuveen
Charlotte,
North Carolina
|
-$202M |
| 4 |
Los Angeles Capital Management
Los Angeles,
California
|
-$109M |
| 5 |
CHP
Castle Hook Partners
New York
|
-$101M |
DXCM Hedge Fund Activity: Q1 2026 in Review
962 of the 8,186 institutional investors tracked by Wall St. Rank reported a position in DexCom (DXCM) for Q1 2026, worth a combined $23.4B — down 6% from $24.9B a quarter earlier.
Buyers outnumbered sellers: 152 funds opened new DXCM positions and 97 closed out — a net gain of 55 holders — while 375 added to existing stakes and 324 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $435M. The largest seller was Jennison Associates, cutting an estimated $330M.
- 962 institutional investors held DexCom (DXCM) as of Q1 2026, up from 922 in Q4 2025.
- Funds reported $23.4B of DexCom stock for Q1 2026, down 6% quarter-over-quarter.
- 152 funds opened new DexCom positions in Q1 2026 and 97 closed out, a net change of +55 holders.
- The largest DexCom buyer in Q1 2026 was Wellington Management Group, an estimated $435M added.
- The largest DexCom seller in Q1 2026 was Jennison Associates, an estimated $330M sold.
Based on aggregated 13F filings for Q1 2026.